Hua Medicine (Shanghai) Ltd. (02552.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

2.1x

EV/EBITDA

−4.6x

Market Cap

HKD 2.42B

MomentumView details →

1D Return

−3.17%

YTD Return

−25.65%

RSI (14)

39.6

ValuationView details →

P/E (Fwd)

2.1x

EV/EBITDA

−4.6x

Market Cap

HKD 2.42B

RSI (14)

39.6

MomentumView details →

1D Return

−3.17%

YTD Return

−25.65%

ProfitabilityView details →

Gross Margin

57.69%

Net Margin

95.54%

EBITDA Margin

−28.96%

ROE (TTM)

97.73%

ROA (TTM)

64.03%

Asset Turnover

0.68x

GrowthView details →

Revenue YoY

+415.69%

EPS YoY

+313.62%

FCF YoY

—

Revenue CAGR 3Y

+201.05%

EPS CAGR 3Y

+536.00%

EBITDA YoY

+53.27%

EarningsView details →

EPS (Actual)

−HKD 0.03

EPS Surprise

83.79%

Beats (12Q)

1/12

Next Q EPS Est

−HKD 0.25

Avg Surprise (4Q)

83.79%

Rev Surprise

−23.17%

Capital & dividendView details →

Debt/Equity

0.36x

Current Ratio

3.34x

Quick Ratio

3.05x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.02B

Net Income (TTM)

969.97M

Op. CF (TTM)

—

Next earningsApr 1, 2027 →

Latest newsMore news →

Huaming Medicine issued a profit warning, expecting a net loss of about 30.2 million RMB for the six months ending June 30, 2026, compared to a profit of about 1.184 billion RMB in the same period last year.29d ago

Similar companies

Bausch Health Companies Inc.BHC 圣达生物603079.SH HUTCHMED (China) LimitedHCM Supernus Pharmaceuticals, Inc.SUPN Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.01349.HK Chia Tai Enterprises International Limited03839.HK Find similar companies →

Latest newsMore news →

Huaming Medicine issued a profit warning, expecting a net loss of about 30.2 million RMB for the six months ending June 30, 2026, compared to a profit of about 1.184 billion RMB in the same period last year.29d ago